OR9G1
Olfactory receptor 9G1
Also known as: OR9G1_HUMAN, OR9G5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NH87
- Gene
- OR9G1
- Ensembl
- ENSG00000174914
- Chromosome
- 11
- Canonical length
- 305 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
305 residues, UniProt reviewed canonical sequence.
>Q8NH87|OR9G1
1 MQRSNHTVTE FILLGFTTDP GMQLGLFVVF LGVYSLTVVG NSTLIVLICN DSCLHTPMYF
61 FTGNLSFLDL WYSSVYTPKI LVTCISEDKS ISFAGCLCQF FFSAGLAYSE CYLLAAVAYD
121 RYVAISKPLL YAQAMSIKLC ALLVAVSYCG GFINSSIITK KTFSFNFCRE NIIDDFFCDL
181 LPLVELACGE KGGYKIMMYF LLASNVICPA VLILASYLFI ITSVLRISSS KGYLKAFSTC
241 SSHLTSVTLY YGSILYIYAL PRSSYSFDMD KIVSTFYTVV FPMLNLMIYS LRNKDVKEAL
301 KKLLPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OR9G1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 0 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
- appendix: 0 nTPM
- basal ganglia: 0 nTPM
- blood vessel: 0 nTPM
Single-cell type
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
- alveolar cells type 1: 0 nCPM
- alveolar cells type 2: 0 nCPM
- astrocytes: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 1.5 nTPM
- hypothalamus: 0.5 nTPM
- pons: 0.5 nTPM
- white matter: 0.5 nTPM
- cerebral cortex: 0.4 nTPM
- medulla oblongata: 0.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.78
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.64
- DepMap mean gene effect
- -0.2
- DepMap dependency class
- selective
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OR9G1 as an antibody target. Whether an autoantibody or antibody against OR9G1 could matter depends on whether native OR9G1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OR9G1 is annotated at the cell surface, where native OR9G1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label OR9G1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...